[ET Net News Agency, 7 January 2026] INNOVENT BIO (01801) rose 5.3% to HK$88.95.
It hits an intra-day high of HK$88.95, breaking above the 50-D SMA of HK$86.708, and an intra-day low of HK$84.3. The total shares traded was 15.49 million, with a value of HK$1.35b. The active buy/sell ratio is 58:42, with net buying turnover of HK$219.37m. MORGAN STANLEY HK SEC accounts for greatest net responsive buying turnover of HK$12.48m, with volume weighted average price of HK$86.405. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$57.57m, with volume weighted average price of HK$86.723. The stock has risen a combined 16.7% over the past 4 consecutive trading days.
The Hang Seng Index now fell 299 points, or 1.1% to 26,410; the Hang Seng China Enterprises Index now fell 119 points, or 1.3% to 9,124.
Basic Information| Nominal | 88.950 | % Chg | +5.27% |
| High | 88.950 | Low | 84.300 |
| Shares Tr | 15.49m | Turnover | 1.35b |
| 10-D SMA | 81.385 | %H.V | 43.923 |
| 20-D SMA | 82.222 | VWAP | 86.869 |
| 50-D SMA | 86.708 | RSI14 | 59.117 |
Status: Breaking above the 50-D SMA, active buy/sell ratio is 58:42, with net buying turnover of HK$219.37m, rising a combined 16.7% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOVENT BIO (01801) | 88.95 | +5.27 |
| CSPC PHARMA (01093) | 9.12 | +2.93 |
| SINO BIOPHARM (01177) | 6.81 | +3.50 |
| HENGRUI PHARMA (01276) | 76.45 | +2.55 |
| WUXI BIO (02269) | 35.94 | +5.40 |
| WUXI APPTEC (02359) | 110.30 | +4.25 |
| ZIJIN MINING (02899) | 37.90 | -0.94 |
| HANSOH PHARMA (03692) | 39.90 | +3.42 |
| BEONE MEDICINES (06160) | 197.60 | +2.76 |
| AKESO (09926) | 128.30 | +6.56 |
(ed)
